Skip to main content
. Author manuscript; available in PMC: 2013 Nov 1.
Published in final edited form as: Liver Transpl. 2012 Oct 10;18(11):1302–1309. doi: 10.1002/lt.23537

Table 6.

Outcomes of applications for 15 exception points

N (% of total applicants for 15 points) Transplanted, N (%)* Laboratory MELD at OLT, median (IQR) Allocation MELD at OLT Removed for death or clinical deterioration** Days from listing to death, median (IQR) ††
All applications approved 223 (74.1) 158 (72.1) 11 (9–14) 15 (15–16) 19(8.5) 318 (126–1309)
Applications both accepted and rejected 15 (5.0) 5 (35.7) 10 (8–11) 15 (15–15) 2 (13.3) 386 (243–529)
All applications rejected 63 (20.9) 34(54.0) 12 (11–14) 15 (12–18) 9 (14.3) 889 (404–1544)
*

p=0.001 comparing three groups

p=0.11comparing three groups. 158/197 (80.2%) of patients had a laboratory MELD score less than 15 at the time of transplantation

p=0.19comparing three groups

**

p=0.36comparing three groups

††

p=0.41comparing groups

MELD: Model for End-Stage Liver Disease

OLT: Orthotopic Liver Transplant

IQR: Interquartile Range